CARDIFF ONCOLOGY, INC. Deferred Tax Assets, Operating Loss Carryforwards
CARDIFF ONCOLOGY, INC. (CRDF) had Deferred Tax Assets, Operating Loss Carryforwards of $31.98 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $31.98M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $27.37M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $23.44M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $20.29M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $31.98M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $27.37M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $23.44M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $20.29M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $17.51M 10-K · filed 2023-03-02 | $47.90M 10-K · filed 2022-02-24 |
| 2020-12-31 | $42.33M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $38.49M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $35.02M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $29.71M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $41.50M 10-K · filed 2018-02-26 | $41.50K 10-K · filed 2017-03-15 |
| 2015-12-31 | $28.00K 10-K · filed 2017-03-15 | $27.96M 10-K · filed 2016-03-10 |
| 2014-12-31 | $19.01M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $14.21M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $10.91M 10-K · filed 2014-03-17 | |
| 2011-12-31 | $9.36M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |